Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Randomized Study of Atezolizumab Plus Multi-Kinase Inhibitor Versus Multi-Kinase Inhibitor Alone in Subjects With Unresectable, Advanced Hepatocellular Carcinoma Who Previously Received Atezolizumab Plus Bevacizumab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05168163
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:18.183786+00:00
Published At
2025-09-16T00:00:00+00:00
Record Updated At
2025-09-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Hepatocellular Carcinoma", "Metastatic Hepatocellular Carcinoma", "Stage III Hepatocellular Carcinoma AJCC v8", "Stage IIIA Hepatocellular Carcinoma AJCC v8", "Stage IIIB Hepatocellular Carcinoma AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IVA Hepatocellular Carcinoma AJCC v8", "Stage IVB Hepatocellular Carcinoma AJCC v8", "Unresectable Hepatocellular Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-16"
protocolSection.identificationModule.nctId
"NCT05168163"
protocolSection.identificationModule.officialTitle
"A Phase II Randomized Study of Atezolizumab Plus Multi-Kinase Inhibitor Versus Multi-Kinase Inhibitor Alone in Subjects With Unresectable, Advanced Hepatocellular Carcinoma Who Previously Received Atezolizumab Plus Bevacizumab"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Locally Advanced Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.